Physician profile
Daniel Tamez
NPI 1831195957
$2,429.70
in general payments reported to CMS, 2019-2025
13 companies · $20.81 in 2025
The $20.81 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $1,530 · 2021: $274 · 2022: $108 · 2023: $26.55 · 2025: $20.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artegraft INC. | $1,000.00 | 2020 | |
| Medtronic Vascular, INC. | $925.99 | 2019-2020 | |
| Medtronic, INC. | $179.04 | 2021 | |
| Misonix INC | $84.05 | 2021 | |
| W. L. Gore & Associates, INC. | $62.88 | 2022 | |
| Angiodynamics, INC. | $33.12 | 2022 | |
| Philips North America LLC | $32.19 | 2019 | |
| Boston Scientific Corporation | $28.46 | 2020 | |
| Tactile Systems Technology INC | $26.55 | 2023 | Flexitouch Plus, Entre Plus |
| Tris Pharma INC | $20.81 | 2025 | Onyda Xr |
| Janssen Pharmaceuticals, INC | $13.22 | 2019 | |
| Abbvie INC. | $12.15 | 2022 | |
| Smith+Nephew, INC. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tamez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.